Resistance to ceftazidime-Avibactam in klebsiella pneumoniae due to porin mutations & the increased expression of KPC-3

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 6, 2017, Pages

  Humphries, Romney M ^a   Hemarajata, Peera ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ceftazidime Avibactam; KPC; OmpK35; OmpK36; Resistance

Indexed keywords

AVIBACTAM PLUS CEFTAZIDIME; BACTERIAL PROTEIN; KPC 3 PROTEIN; MEROPENEM; PORIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; AVIBACTAM, CEFTAZIDIME DRUG COMBINATION; AZABICYCLO DERIVATIVE; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA-LACTAMASE KPC-3, KLEBSIELLA PNEUMONIAE; BETA-LACTAMASE SHV-11; BETA-LACTAMASE SHV-12; CEFTAZIDIME; OMPK36 PROTEIN, KLEBSIELLA PNEUMONIAE;

ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; BACTERIAL MUTATION; BACTERIUM ISOLATE; FRAMESHIFT MUTATION; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPOSON; WHOLE GENOME SEQUENCING; BACTERIAL GENOME; BIOSYNTHESIS; DRUG COMBINATION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; BACTERIAL PROTEINS; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; CEFTAZIDIME; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; POLYMORPHISM, SINGLE NUCLEOTIDE; PORINS; WHOLE GENOME SEQUENCING;

EID: 85019677848     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00537-17     Document Type: Letter

References (11)

1. Humphries RM, Yang S, Hemarajata P, Ward KW, Hindler JA, Miller SA, Gregson A. 2015. First report of ceftazidime-Avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 59:6605- 6607. https://doi.org/10.1128/AAC.01165-15.
2. Yang S, Hemarajata P, Hindler J, Li F, Adisetiyo H, Aldrovandi G, Sebra R, Kasarskis A, MacCannell D, Didelot X, Humphries RM. 2017. Evolution and transmission of carbapenem-resistant Klebsiella pneumoniae expressing the blaOXA-232 gene during an institutional outbreak associated with endoscopic retrograde cholangiopancreatography. Clin Infect Dis 64:894 -901. https://doi.org/10.1093/cid/ciw876.
3. Bowers JR, Kitchel B, Driebe EM, MacCannell DR, Roe C, Lemmer D, de Man T, Rasheed JK, Engelthaler DM, Keim P, Limbago BM. 2015. Genomic analysis of the emergence and rapid global dissemination of the clonal group 258 Klebsiella pneumoniae pandemic. PLoS One 10:e0133727. https://doi.org/10.1371/journal.pone.0133727.
4. Shields RK, Clancy CJ, Hao B, Chen L, Press EG, Iovine NM, Kreiswirth BN, Nguyen MH. 2015. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum beta-lactamases, and porin mutations on the in vitro activity of ceftazidime-Avibactam against carbapenemresistant K. pneumoniae. Antimicrob Agents Chemother 59:5793-5797. https://doi.org/10.1128/AAC.00548-15.
5. Naas T, Cuzon G, Truong HV, Nordmann P. 2012. Role of ISKpn7 and deletions in blaKPC gene expression. Antimicrob Agents Chemother 56:4753- 4759. https://doi.org/10.1128/AAC.00334-12.
6. Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries RM. 2014. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol 52:4003- 4009. https://doi.org/10.1128/JCM.01397-14.
7. Castanheira M, Mills JC, Costello SE, Jones RN, Sader HS. 2015. Ceftazidime-Avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of betalactamase- producing strains. Antimicrob Agents Chemother 59: 3509-3517. https://doi.org/10.1128/AAC.00163-15.
8. Grobner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. 2009. Emergence of carbapenem-non-susceptible extendedspectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58:912-922. https://doi.org/10.1099/jmm.0.005850-0.
9. Findlay J, Hamouda A, Dancer SJ, Amyes SG. 2012. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 18:140 -146. https://doi.org/10.1111/j.1469-0691.2011.03515.x.
10. Pages JM, Peslier S, Keating TA, Lavigne JP, Nichols WW. 2015. Role of the outer membrane and porins in susceptibility of beta-lactamaseproducing Enterobacteriaceae to ceftazidime-Avibactam. Antimicrob Agents Chemother 60:1349 -1359. https://doi.org/10.1128/AAC.01585-15.
11. Castanheira M, Mendes RE, Sader HS. 2017. Low frequency of ceftazidimeavibactam resistance among Enterobacteriaceae isolates carrying blaKPC collected in hospitals from the United States from 2012 to 2015. Antimicrob Agents Chemother 61:e02369-16. https://doi.org/10.1128/AAC.02369-16.